https://www.marketscreener.com/quote/stock/SYNDAX-PHARMACEUTICALS-IN-16725742/news/Syndax-Pharmaceuticals-Inc-Blog-Exposure-Syndax-Pharma-Shares-Results-of-Phase-2-ENCORE-601-Tria-26626472/?utm_source=telegram&utm_medium=social&utm_campaign=share